Order Article Reprints

da Silva EZM, Fraga-Silva TFdC, Yuan Y, Alves MG, Publio GA, da Fonseca CK, Kodama MH, Vieira GV, Candido MF, Innocentini LMAR, et al. Kallikrein 5 Inhibition by the Lympho-Epithelial Kazal-Type Related Inhibitor Hinders Matriptase-Dependent Carcinogenesis. Cancers. 2021; 13(17):4395. https://doi.org/10.3390/cancers13174395

da Silva, Elaine Zayas Marcelino, Thais Fernanda de Campos Fraga-Silva, Yao Yuan, Márcia Gaião Alves, Gabriel Azevedo Publio, Carol Kobori da Fonseca, Márcio Hideki Kodama, Gabriel Viliod Vieira, Marina Ferreira Candido, Lara Maria Alencar Ramos Innocentini, and et al. 2021. "Kallikrein 5 Inhibition by the Lympho-Epithelial Kazal-Type Related Inhibitor Hinders Matriptase-Dependent Carcinogenesis" Cancers 13, no. 17: 4395. https://doi.org/10.3390/cancers13174395

da Silva, E. Z. M., Fraga-Silva, T. F. d. C., Yuan, Y., Alves, M. G., Publio, G. A., da Fonseca, C. K., Kodama, M. H., Vieira, G. V., Candido, M. F., Innocentini, L. M. A. R., Miranda, M. G., da Silva, A. R., Alves-Filho, J. C., Bonato, V. L. D., Iglesias-Bartolome, R., & Sales, K. U. (2021). Kallikrein 5 Inhibition by the Lympho-Epithelial Kazal-Type Related Inhibitor Hinders Matriptase-Dependent Carcinogenesis. Cancers, 13(17), 4395. https://doi.org/10.3390/cancers13174395